☆ 4.5 Editorial Material

Commentary: Objective aids for the assessment of ADHD - further clarification of what FDA approval for marketing means and why NEBA might help clinicians. A response to Arns et al. (2016)

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2016)

Get Full Text
Add to Collection

Journal

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
Volume 57, Issue 6, Pages 770-771

Publisher

WILEY
DOI: 10.1111/jcpp.12534

Keywords

-

Categories

Psychology, Developmental Psychiatry Psychology

Funding

  1. Pfizer
  2. Ironshore Pharmaceuticals
  3. Shire

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.